WeVote
Log In

Bill

Bill

ACR 87

Relative to Amyotrophic Lateral Sclerosis Awareness Month.

2025-2026 Regular Session Introduced by Dawn Addis and 75 co-sponsors

California designates a month as ALS Awareness Month to increase public recognition and support for the neurodegenerative disease and affected communities.

Chaptered by Secretary of State - Res. Chapter 108, Statutes of 2025.
#amyotrophiclateralsclerosisawarenessmonth
0
WeVote Research Nonpartisan
Bill Summary · ACR 87

Legislative bill overview

ACR 87 designates a specific month in California as Amyotrophic Lateral Sclerosis (ALS) Awareness Month. This is a concurrent resolution—a symbolic legislative action that does not carry the force of law but expresses the state legislature's recognition and support for increased awareness of the disease.

Why is this important

ALS is a progressive neurodegenerative disease with no cure and a median survival of 2-3 years after diagnosis. Awareness campaigns can help with early detection, fundraising for research, and support for patients and families. The designation provides an official platform to highlight the disease and potentially drive public attention and resources toward ALS-related causes.

Potential points of contention

  • Symbolic vs. substantive action: While awareness designations are well-intentioned, critics may argue the legislature should pair such resolutions with concrete funding for research, patient services, or medical infrastructure rather than symbolic gestures alone.
  • Month selection and competing causes: Designating specific months for various conditions raises questions about fairness—numerous diseases compete for public attention, and some may argue resources should prioritize higher-incidence conditions.
  • Implementation clarity: The resolution does not specify what mechanisms will actually promote awareness or ensure the designation translates into tangible benefits for the ALS community.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.